BSX Stock Recent News

BSX LATEST HEADLINES

BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.47 per share a year ago.

Zacks Investment Research 2024 Apr 24
BSX Stock News Image - Barrons

The medical-device company tops first-quarter sales and profit estimates.

Barrons 2024 Apr 24
BSX Stock News Image - Reuters

Medical device maker Boston Scientific raised its annual profit forecast on Wednesday as the company banks on resilient demand for its heart devices, with post-pandemic elective surgical procedures picking up pace.

Reuters 2024 Apr 24
BSX Stock News Image - Market Watch

Boston Scientific Corp.'s stock BSX, +1.43% rose 2.7% early Wednesday, after the medical tech company's first-quarter earnings beat analyst estimates. The company had net income of $495 million, or 33 cents a share, for the quarter, up from $300 million, or 21 cents a share, in the year-earlier period.

Market Watch 2024 Apr 24
BSX Stock News Image - Zacks Investment Research

Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.

Zacks Investment Research 2024 Apr 19
BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.

Zacks Investment Research 2024 Apr 16
BSX Stock News Image - Zacks Investment Research

With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.

Zacks Investment Research 2024 Apr 10
BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement.

Zacks Investment Research 2024 Mar 28
BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) is consistently registering fast recovery within its MedSurg segment in the post-pandemic period.

Zacks Investment Research 2024 Mar 18
BSX Stock News Image - Zacks Investment Research

The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.

Zacks Investment Research 2024 Mar 04
10 of 50